Explore
Therapeutic Landscapes in Colorectal Carcinoma
0 Ungluers have
Faved this Work
Login to Fave
The Special Issue, titled “Therapeutic Landscapes in Colorectal Carcinoma”, illustrates a stimulating collection of articles written by international specialists that can promote discussions and ideas among colleagues working on CRC. It provides us with a deeper insight into the latest advances involving knowledge on CRC from scientific, translational, and clinical points of view. Through this Special Issue, our main purpose was to shed light on some state-of-the-art research on CRC. Here, the reader will find papers on prognostic factors as well as responses to neoadjuvant and adjuvant CRC treatments. Finally, we discuss the research trends and hotspots for CRC therapies that emerged during the COVID-19 pandemic, such as the potential achievement of a transition from CRC clinical research to precision medicine, together with a special emphasis given to new single-cell-based techniques. We hope that it can encourage translational and interdisciplinary collaborations, leading to a definitive understanding of strategies to overcome and inhibit CRC progression and metastasis.
This book is included in DOAB.
Why read this book? Have your say.
You must be logged in to comment.
Rights Information
Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.Downloads
This work has been downloaded 11 times via unglue.it ebook links.
- 11 - pdf (CC BY) at Unglue.it.
Keywords
- adjuvant therapy
- BRAF mutation
- Cancer
- cancer therapeutics
- cell line models
- chemotherapy
- Clinical & internal medicine
- colon cancer
- colorectal
- colorectal cancer
- colorectal cancer screening
- colorectal carcinoma
- COVID-19
- Databases
- de novo malignancy
- dependencies
- Diseases & disorders
- dMMR
- Drug development
- IHC
- Immunosuppression
- Immunotherapy
- incidence
- inflammatory pathways
- intratumor heterogeneity
- Liver transplantation
- locally advanced colon cancer (LACC)
- medicine
- metastatic colorectal cancer
- MSI
- n/a
- neoadjuvant chemotherapy (NAC)
- NFkB
- oncology
- PCR
- precision medicine
- preclinical candidates
- preoperative treatment
- propensity score matching
- Regorafenib
- RIPK2
- Romania
- SARS-CoV-2
- signal transduction
- single-cell next-generation sequencing
- stage IIA
- Survival
- targeted therapies
- targeted therapy
- TGF-b
- triple target therapy
- uracil–tegafur
Links
DOI: 10.3390/books978-3-0365-9440-8Editions